Evidence map›Paper›PMID 26867675›Full record

ArticleJournal of neuroinflammation2016

TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function.

Justin Rustenhoven, Miranda Aalderink, Emma L Scotter, Robyn L Oldfield, Peter S Bergin, Edward W Mee, E Scott Graham, Richard L M Faull, Maurice A Curtis, Thomas I-H Park and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 2 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 2 syntheses or guidelines pooled it, 197 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Eppur si muove: the dynamic brain pericyte.Fluids and barriers of the CNS · 2025
    Review
  16. Pericytes in the optic nerve head.Progress in retinal and eye research · 2025
    Review
  17. Article
  18. Article
  19. A comprehensive review of cerebral malaria.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Review
  20. Review

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Justin RustenhovenDepartment of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, 1023, New Zealand.
Miranda AalderinkDepartment of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, 1023, New Zealand.
Emma L ScotterDepartment of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, 1023, New Zealand.
Robyn L OldfieldLab Plus, Auckland, 1023, New Zealand.
Peter S BerginCentre for Brain Research, The University of Auckland, Auckland, 1023, New Zealand.
Edward W MeeCentre for Brain Research, The University of Auckland, Auckland, 1023, New Zealand.
E Scott GrahamDepartment of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, 1023, New Zealand.
Richard L M FaullDepartment of Anatomy, The University of Auckland, Auckland, 1023, New Zealand.
Maurice A CurtisDepartment of Anatomy, The University of Auckland, Auckland, 1023, New Zealand.
Thomas I-H ParkDepartment of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, 1023, New Zealand.
Mike DragunowDepartment of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, 1023, New Zealand. m.dragunow@auckland.ac.nz.
University of Auckland · NZAuckland City Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransforming growth factor beta 1 (TGFβ1) is strongly induced following brain injury and polarises microglia to an anti-inflammatory phenotype. Augmentation of TGFβ1 responses may therefore be beneficial in preventing inflammation in neurological disorders including stroke and neurodegenerative diseases. However, several other cell types display immunogenic potential and identifying the effect of TGFβ1 on these cells is required to more fully understand its effects on brain inflammation. Pericytes are multifunctional cells which ensheath the brain vasculature and have garnered recent attention with respect to their immunomodulatory potential. Here, we sought to investigate the inflammatory phenotype adopted by TGFβ1-stimulated human brain pericytes.

methodsMicroarray analysis was performed to examine transcriptome-wide changes in TGFβ1-stimulated pericytes, and results were validated by qRT-PCR and cytometric bead arrays. Flow cytometry, immunocytochemistry and LDH/Alamar Blue® viability assays were utilised to examine phagocytic capacity of human brain pericytes, transcription factor modulation and pericyte health.

resultsTGFβ1 treatment of primary human brain pericytes induced the expression of several inflammatory-related genes (NOX4, COX2, IL6 and MMP2) and attenuated others (IL8, CX3CL1, MCP1 and VCAM1). A synergistic induction of IL-6 was seen with IL-1β/TGFβ1 treatment whilst TGFβ1 attenuated the IL-1β-induced expression of CX3CL1, MCP-1 and sVCAM-1. TGFβ1 was found to signal through SMAD2/3 transcription factors but did not modify nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) translocation. Furthermore, TGFβ1 attenuated the phagocytic ability of pericytes, possibly through downregulation of the scavenger receptors CD36, CD47 and CD68. Whilst TGFβ did decrease pericyte number, this was due to a reduction in proliferation, not apoptotic death or compromised cell viability.

conclusionsTGFβ1 attenuated pericyte expression of key chemokines and adhesion molecules involved in CNS leukocyte trafficking and the modulation of microglial function, as well as reduced the phagocytic ability of pericytes. However, TGFβ1 also enhanced the expression of classical pro-inflammatory cytokines and enzymes which can disrupt BBB functioning, suggesting that pericytes adopt a phenotype which is neither solely pro- nor anti-inflammatory. Whilst the effects of pericyte modulation by TGFβ1 in vivo are difficult to infer, the reduction in pericyte proliferation together with the elevated IL-6, MMP-2 and NOX4 and reduced phagocytosis suggests a detrimental action of TGFβ1 on neurovasculature.

Indexed as

BrainCell ProliferationCell SurvivalCulture Media, ConditionedCyclooxygenase 2CytokinesGene Expression RegulationHumansInterleukin-1betaMatrix Metalloproteinase 2NADPH Oxidase 4NADPH OxidasesNF-kappa BPericytesPhagocytesReceptors, ScavengerCulture Media, ConditionedCyclooxygenase 2CytokinesInterleukin-1betaMatrix Metalloproteinase 2NADPH Oxidase 4NADPH OxidasesNF-kappa BNOX4 protein, humanPTGS2 protein, humanReceptors, ScavengerSmad2 ProteinTransforming Growth Factor beta1Vascular Cell Adhesion Molecule-1

Identifiers

PMID26867675
PMCPMC4751726
OpenAlexW2280695772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.